Mutations in components of the NADPH oxidase complex—such as CYBB, encoding the catalytic subunit gp91phox—cause chronic granulomatous disease (CGD) in both humans and mice, leading to recurrent infections with catalase-positive bacteria and fungi (47, 47, 48). This evidence concerns the gene FMO5 and chronic granulomatous disease.